Emad Mahmoud Elrewiny
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Emad Mahmoud Elrewiny has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Hazem B. Zakaria
Department of Dermatology, Venereology & Andrology, Faculty of Medicine, Al-Azhar University, Cairo.
2 shared publications - Waleed Ahmed Mahmoud
Department of Dermatology, Venereology & Andrology, Faculty of Medicine, Al-Azhar University, Cairo.
2 shared publications Ahmed A. Suliman
Department of Dermatology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
1 shared publicationAhmed Abdelkader Mohamed
Department of Dermatology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt
1 shared publication- Ahmed E Elsaadany
Department of Dermatology, Venereology & Andrology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt...
1 shared publication - Ahmed F. El-Sherbeiny
Department of Andrology, International Islamic Center for Population Studies and Research, Al-Azhar University, Cairo.
1 shared publication
Latest Publications
- Open Access
- 30 June 2025
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 97 (2) , 13938
The changes of semen parameters of patients with clinical versus subclinical varicocele managed by laparoscopic varicocelectomy: observational study
Objectives: To assess the effectiveness of laparoscopic varicocelectomy in patients with clinical versus subclinical varicocele concerning preoperative and postoperative seminal parameters. Patients and methods: Between February 2021 and August 2024, a total of 162 patients diagnosed with varicocele (72 with subclinical and 90 with clinical presentation) seeking infertility advice (primary or secondary) at the author's institution underwent laparoscopic varicocelectomy and were enrolled in the study. All patients underwent history taking, clinical examination, semen analysis, and scrotal colour Doppler ultrasonography. Patients with recurrent varicocele, azoospermia, or infertility due to causes other than varicocele were excluded from the study. Semen analysis was conducted for all patients before laparoscopic varicocelectomy and 3 to 6 months after varicocelectomy. Results: Significant improvements in seminal parameters were observed in patients with clinical varicocele (p < 0.05). Bilateral and right-sided varicoceles were more prevalent in patients with subclinical varicocele. Additionally, the incidence of secondary infertility was higher in patients with subclinical varicocele compared to those with clinical varicocele (p<0.05). Conclusions: Our study indicates favourable outcomes of laparoscopic varicocelectomy in patients with clinical varicocele. Regarding the effects of varicocelectomy in patients with subclinical varicocele, we recommend avoiding varicocelectomy in subclinical group of patients unless no identifiable causes of semen abnormality.
- 30 June 2025
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 97 (2) , 13938
Open AccessThe changes of semen parameters of patients with clinical versus subclinical varicocele managed by laparoscopic varicocelectomy: observational study
Objectives: To assess the effectiveness of laparoscopic varicocelectomy in patients with clinical versus subclinical varicocele concerning preoperative and postoperative seminal parameters. Patients and methods: Between February 2021 and August 2024, a total of 162 patients diagnosed with varicocele (72 with subclinical and 90 with clinical presentation) seeking infertility advice (primary or secondary) at the author's institution underwent laparoscopic varicocelectomy and were enrolled in the study. All patients underwent history taking, clinical examination, semen analysis, and scrotal colour Doppler ultrasonography. Patients with recurrent varicocele, azoospermia, or infertility due to causes other than varicocele were excluded from the study. Semen analysis was conducted for all patients before laparoscopic varicocelectomy and 3 to 6 months after varicocelectomy. Results: Significant improvements in seminal parameters were observed in patients with clinical varicocele (p < 0.05). Bilateral and right-sided varicoceles were more prevalent in patients with subclinical varicocele. Additionally, the incidence of secondary infertility was higher in patients with subclinical varicocele compared to those with clinical varicocele (p<0.05). Conclusions: Our study indicates favourable outcomes of laparoscopic varicocelectomy in patients with clinical varicocele. Regarding the effects of varicocelectomy in patients with subclinical varicocele, we recommend avoiding varicocelectomy in subclinical group of patients unless no identifiable causes of semen abnormality.
- 1 April 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-9
Fractional CO2 laser with topical insulin versus PRP for atrophic acne scars: a randomized split-face study
Atrophic acne scarring is a prevalent problem that has been treated with a variety of procedures, each with various degrees of success. For better results, combined regimens of treatment are recommended. Our aim was to compare the efficacy of topical insulin against topical platelet-rich plasma (PRP) as an adjunct treatment to fractional CO2 laser for atrophic acne scars. The study comprised 30 patients with atrophic acne scars. All patients underwent four sessions of fractional CO2 laser on both sides of the face at one-month intervals, followed by topical PRP treatment on one side of the face and topical insulin on the other. Two non-treating dermatologists used the Acne Scar Assessment Scale (ASAS) to assess the outcome. At their last follow-up appointment, patients were asked to assess their improvement on each side of the face in a percentage from 0 to 100%. Prior to treatment, there was no difference in the ASAS scores between the two sides of the face. One month after the last treatment session, ASAS scores improved significantly on both sides of the face. No significant difference (p = 0.794) between both sides were detected. Both techniques helped to improve atrophic acne scars and may have a synergistic outcome regarding efficacy and safety.
- 1 April 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-9
Fractional CO2 laser with topical insulin versus PRP for atrophic acne scars: a randomized split-face study
Atrophic acne scarring is a prevalent problem that has been treated with a variety of procedures, each with various degrees of success. For better results, combined regimens of treatment are recommended. Our aim was to compare the efficacy of topical insulin against topical platelet-rich plasma (PRP) as an adjunct treatment to fractional CO2 laser for atrophic acne scars. The study comprised 30 patients with atrophic acne scars. All patients underwent four sessions of fractional CO2 laser on both sides of the face at one-month intervals, followed by topical PRP treatment on one side of the face and topical insulin on the other. Two non-treating dermatologists used the Acne Scar Assessment Scale (ASAS) to assess the outcome. At their last follow-up appointment, patients were asked to assess their improvement on each side of the face in a percentage from 0 to 100%. Prior to treatment, there was no difference in the ASAS scores between the two sides of the face. One month after the last treatment session, ASAS scores improved significantly on both sides of the face. No significant difference (p = 0.794) between both sides were detected. Both techniques helped to improve atrophic acne scars and may have a synergistic outcome regarding efficacy and safety.
- 21 January 2020
- Published by Wiley in Dermatologic Therapy
- Vol. 33 (2) , e13228
Efficacy of intralesional methotrexate in the treatment of plantar warts
Background Warts are tumors or growths caused by infection with Human Papilloma virus (HPV). Currently, over 170 HPV types have been identified. Objective This study aimed to evaluate the efficacy and safety of intralesional injection of methotrexate for the treatment of plantar warts. Patients and Methods Sixty patients presented with plantar warts were divided into 2 groups. Group A patients were injected with intralesional methotrexate (MTX) (2 mg/ml). Group B patients were injected with intralesional saline as a placebo. The injections were repeated every week for a maximum of 6 sessions or until complete clearance, whichever was earlier. The patients were followed up for 6 months after the last injection. Results In the intralesional MTX group, 2 patients (6.7%) showed complete improvement, 8 patients (26.7%) showed partial improvement and 20 patients (66.7%) showed no improvement. In the intralesional saline group, 3 patients (10%) showed complete improvement, 4 patients (13.3%) showed partial improvement and 23 patients (76.7%) showed no improvement. Reported adverse events were local reactions in the form of swelling, pain, and infection in both groups. Conclusion There was no statistically significant difference between the therapeutic responses to intralesional MTX injection and saline.
- 21 January 2020
- Published by Wiley in Dermatologic Therapy
- Vol. 33 (2) , e13228
Efficacy of intralesional methotrexate in the treatment of plantar warts
Background Warts are tumors or growths caused by infection with Human Papilloma virus (HPV). Currently, over 170 HPV types have been identified. Objective This study aimed to evaluate the efficacy and safety of intralesional injection of methotrexate for the treatment of plantar warts. Patients and Methods Sixty patients presented with plantar warts were divided into 2 groups. Group A patients were injected with intralesional methotrexate (MTX) (2 mg/ml). Group B patients were injected with intralesional saline as a placebo. The injections were repeated every week for a maximum of 6 sessions or until complete clearance, whichever was earlier. The patients were followed up for 6 months after the last injection. Results In the intralesional MTX group, 2 patients (6.7%) showed complete improvement, 8 patients (26.7%) showed partial improvement and 20 patients (66.7%) showed no improvement. In the intralesional saline group, 3 patients (10%) showed complete improvement, 4 patients (13.3%) showed partial improvement and 23 patients (76.7%) showed no improvement. Reported adverse events were local reactions in the form of swelling, pain, and infection in both groups. Conclusion There was no statistically significant difference between the therapeutic responses to intralesional MTX injection and saline.